Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$4.7 - $9.87 $1.41 Million - $2.95 Million
299,380 New
299,380 $1.96 Million
Q3 2023

Nov 13, 2024

BUY
$9.14 - $12.85 $2.74 Million - $3.85 Million
299,380 New
299,380 $2.99 Million
Q3 2023

Nov 13, 2023

SELL
$9.14 - $12.85 $12.6 Million - $17.7 Million
-1,377,539 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$12.09 - $15.0 $6.63 Million - $8.22 Million
548,136 New
548,136 $6.81 Million
Q2 2023

Aug 14, 2023

SELL
$12.09 - $15.0 $12.4 Million - $15.4 Million
-1,027,824 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$12.99 - $16.48 $11.7 Million - $14.9 Million
903,760 New
903,760 $12.7 Million
Q4 2022

Feb 14, 2023

BUY
$12.5 - $24.78 $24.5 Million - $48.5 Million
1,957,399 New
1,957,399 $28 Million
Q3 2022

Nov 13, 2023

BUY
$20.6 - $30.37 $28.4 Million - $41.8 Million
1,377,539 New
1,377,539 $35.2 Million
Q2 2022

Aug 14, 2023

BUY
$26.05 - $37.48 $26.8 Million - $38.5 Million
1,027,824 New
1,027,824 $29.2 Million
Q1 2022

May 12, 2023

SELL
$24.46 - $40.92 $25.1 Million - $42 Million
-1,025,670 Reduced 52.4%
931,729 $32.9 Million
Q1 2022

May 09, 2022

SELL
$24.46 - $40.92 $22.8 Million - $38.1 Million
-931,729 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$35.0 - $45.94 $32.6 Million - $42.8 Million
931,729 New
931,729 $39 Million
Q3 2021

Nov 14, 2022

BUY
$36.8 - $60.62 $30.8 Million - $50.7 Million
836,580 New
836,580 $41.1 Million
Q3 2021

Nov 05, 2021

SELL
$36.8 - $60.62 $22.8 Million - $37.6 Million
-620,781 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$32.46 - $45.0 $20.2 Million - $27.9 Million
620,781 New
620,781 $25.9 Million
Q1 2021

May 07, 2021

SELL
$25.8 - $38.49 $2 Million - $2.98 Million
-77,418 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$24.5 - $30.86 $1.9 Million - $2.39 Million
77,418 New
77,418 $2.17 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.